10-89225172-CA-CAA
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000235.4(LIPA):c.594dupT(p.Ala199CysfsTer13) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000204 in 1,613,756 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_000235.4 frameshift
Scores
Clinical Significance
Conservation
Publications
- lysosomal acid lipase deficiencyInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Genomics England PanelApp, ClinGen, Myriad Women’s Health, Labcorp Genetics (formerly Invitae)
- cholesteryl ester storage diseaseInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- Wolman diseaseInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000235.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| LIPA | NM_000235.4 | MANE Select | c.594dupT | p.Ala199CysfsTer13 | frameshift | Exon 6 of 10 | NP_000226.2 | ||
| LIPA | NM_001440836.1 | c.726dupT | p.Ala243CysfsTer13 | frameshift | Exon 7 of 11 | NP_001427765.1 | |||
| LIPA | NM_001440837.1 | c.615dupT | p.Ala206CysfsTer13 | frameshift | Exon 6 of 10 | NP_001427766.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| LIPA | ENST00000336233.10 | TSL:1 MANE Select | c.594dupT | p.Ala199CysfsTer13 | frameshift | Exon 6 of 10 | ENSP00000337354.5 | ||
| LIPA | ENST00000428800.5 | TSL:1 | c.594dupT | p.Ala199CysfsTer13 | frameshift | Exon 5 of 7 | ENSP00000388415.1 | ||
| LIPA | ENST00000371837.5 | TSL:2 | c.426dupT | p.Ala143CysfsTer13 | frameshift | Exon 5 of 9 | ENSP00000360903.1 |
Frequencies
GnomAD3 genomes AF: 0.0000198 AC: 3AN: 151898Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000119 AC: 3AN: 251450 AF XY: 0.00 show subpopulations
GnomAD4 exome AF: 0.0000205 AC: 30AN: 1461858Hom.: 0 Cov.: 33 AF XY: 0.0000151 AC XY: 11AN XY: 727240 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000198 AC: 3AN: 151898Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74190 show subpopulations ⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
Age Distribution
ClinVar
Submissions by phenotype
Wolman disease Pathogenic:2
This sequence change creates a premature translational stop signal (p.Ala199Cysfs*13) in the LIPA gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in LIPA are known to be pathogenic (PMID: 23485521). This variant is present in population databases (rs780495201, gnomAD 0.004%). This premature translational stop signal has been observed in individual(s) with LIPA-related conditions (PMID: 8146180, 16255772). ClinVar contains an entry for this variant (Variation ID: 80). For these reasons, this variant has been classified as Pathogenic.
not provided Pathogenic:2
Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed at a significant frequency in large population cohorts (Lek et al., 2016); This variant is associated with the following publications: (PMID: 16255772, 30315827, 8146180)
Cholesteryl ester storage disease Pathogenic:2
This submission and the accompanying classification are no longer maintained by the submitter. For more information on current observations and classification, please contact variantquestions@myriad.com.
LIPA-related disorder Pathogenic:1
The LIPA c.594dupT variant is predicted to result in a frameshift and premature protein termination (p.Ala199Cysfs*13). This variant, in combination with a second pathogenic variant, has reported to be causative for Wolman disease (Anderson et al., 1994. PubMed ID: 8146180; Bernstein DL et al 2013. PubMed ID: 23485521; Tadiboyina VT et al 2005. PubMed ID: 16255772). This variant has been reported as c.634insT and c.594insT. This variant is reported in 0.0040% of alleles in individuals of African descent in gnomAD (http://gnomad.broadinstitute.org/variant/10-90984929-C-CA). Frameshift variants in LIPA are expected to be pathogenic. This variant is interpreted as pathogenic.
Lysosomal acid lipase deficiency Pathogenic:1
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at